REGN icon

Regeneron Pharmaceuticals
REGN

Upgrade to unlock
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$844
37% upside
High target

2 analyst ratings

positive
1  neutral
50%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Barclays
Barclays
Eliana Merle
0% 1-yr REGN win rate
6 Mar ‘26 2 months ago
RBC Capital
RBC Capital
Brian Abrahams
50% 1-yr REGN win rate
2 Mar ‘26 2 months ago